DGKA

Diacylglycerol kinase alpha · P23743 · DGKA on Sugi Atlas →

84,323 patent compounds predicted against DGKA, 61,399 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Ritanserin Ritanserin (SCHEMBL49227) 1.00 3/20
SCHEMBL15078 SCHEMBL15078 0.69 2/20
SCHEMBL15079 SCHEMBL15079 0.69 2/20
SCHEMBL43555 SCHEMBL43555 0.69 2/20
SCHEMBL43557 SCHEMBL43557 0.69 2/20
SCHEMBL79292 SCHEMBL79292 0.69 2/20
SCHEMBL79293 SCHEMBL79293 0.69 2/20
SCHEMBL79772 SCHEMBL79772 0.69 2/20
SCHEMBL79773 SCHEMBL79773 0.69 2/20
SCHEMBL124225 SCHEMBL124225 0.69 2/20
SCHEMBL124226 SCHEMBL124226 0.69 2/20
SCHEMBL127134 SCHEMBL127134 0.69 2/20
SCHEMBL127136 SCHEMBL127136 0.69 2/20
SCHEMBL130324 SCHEMBL130324 0.69 2/20
SCHEMBL130326 SCHEMBL130326 0.69 2/20
Glyceryl Distearate Glyceryl Distearate (SCHEMBL118948) 0.69 2/20
SCHEMBL93861 SCHEMBL93861 0.65 2/20
SCHEMBL10411 SCHEMBL10411 0.64 2/20
SCHEMBL33706 SCHEMBL33706 0.64 2/20
SCHEMBL42627 SCHEMBL42627 0.64 2/20

Clinical trials — most relevant to DGKA by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With Fenofibrate PHASE2/PHASE3WITHDRAWN
The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus PHASE3UNKNOWN
Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD) PHASE2COMPLETED
Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old PHASE2ACTIVE_NOT_RECRUITING
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides PHASE1COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Duality of Lipids: the Athlete's Paradox nanCOMPLETED
Free Fatty Acid Induced Insulin Resistance nanCOMPLETED
Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on Insulin Resistance in Humans nanCOMPLETED
Tissue Lipids and Insulin Resistance nanWITHDRAWN
A 12 Week, 3-Period Study to Evaluate the Effects of a Dietary Supplement on Lipid Metabolism nanCOMPLETED
The Role of Arachidonic Acid Metabolites, From Patients With Metabolic Syndrome nanUNKNOWN
Study of Changes in Skeletal Muscle After Caloric Restriction nanACTIVE_NOT_RECRUITING
The Study Aims to Investigate the Effects of Oral Inositols on Insulin-resistance in Children With Obesity. nanUNKNOWN
Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAH nanCOMPLETED
Evaluation of Botanicals for Mechanisms Related to Appetite and Fat Metabolism nanCOMPLETED
Novel Inhibitors of Lipolysis in the Treatment of Lipid a Glucose Metabolism in Obstructive Sleep Apnea Syndrome nanUNKNOWN
Effect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity. nanCOMPLETED
Effect of Age on Glucose and Lipid Metabolism nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Intravenous Terbutaline in Severe Status Asthmaticus nanUNKNOWN
A Case Control Study of Resveratrol Effects in Coronary Artery Disease Patients With Metabolic Syndrome nanCOMPLETED
Effects of Obesity and Intensity of Exercise on Ghrelin Levels nanCOMPLETED
Effects of Fish Oils on Inflammation and Insulin Resistance nanCOMPLETED
Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia nanRECRUITING
Evaluation of Plasma Sphingosine-1-Phosphate as A Diagnostic and Prognostic Biomarkers of Community-Acquired Pneumonia nanUNKNOWN
A Longitudinal Study on Short-term Effects of Gastric Bypass on Glucose Homeostasis in Obesity nanCOMPLETED
The Role of Programmed Death Ligand -1 (Pdl-1) in Lung Cancer nanCOMPLETED
Effect of Esterogen Receptor Modulator on Gene in Bipolar Diseas nanNOT_YET_RECRUITING
Extracellular Vesicles, Insulin Action, and Exercise nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a DGKA binder may also engage these)

ProteinNameSimilarity
P20192 1.000 P20192 →
DGKG Diacylglycerol kinase gamma 1.000 landscape →
DGKB Diacylglycerol kinase beta 1.000 landscape →
Q91WG7 1.000 Q91WG7 →
Q03603 1.000 Q03603 →
A0JN54 0.999 A0JN54 →
P51556 0.999 P51556 →
Q39017 0.999 Q39017 →
O88673 0.998 O88673 →
P49621 0.998 P49621 →
P49620 0.996 P49620 →
Q6C710 0.994 Q6C710 →
Q6NS52 0.993 Q6NS52 →
A0A131MCZ8 0.993 A0A131MCZ8 →
Q8IUF1 0.992 Q8IUF1 →
O44476 0.992 O44476 →
Q9TYU5 0.992 Q9TYU5 →
P27730 0.992 P27730 →
B4LX81 0.992 B4LX81 →
Q6CKE9 0.992 Q6CKE9 →
F2Y4A3 0.992 F2Y4A3 →
F4INY4 0.991 F4INY4 →
Q24592 0.991 Q24592 →
O14159 0.991 O14159 →
O94443 0.990 O94443 →
Q5JTY5 0.990 Q5JTY5 →
O76373 0.990 O76373 →
Q4R7L5 0.990 Q4R7L5 →
Q8L7L1 0.990 Q8L7L1 →
Q10028 0.990 Q10028 →